Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
NCT00355862
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
525
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
CNI, MMF, Steroids, Aza etc. (mTOR inhibitor free)
DRUG:
Sirolimus
Sponsor
University of Regensburg